New Genomic Solutions: Identifying Aggressive Prostate Cancer for Pathologists

New Genomic Solutions: Identifying Aggressive Prostate Cancer for Pathologists Course

Learn more about MDxHealth’s biomarker tests to detect the most commonly diagnosed cancer among Veterans — Prostate Cancer. In “New Genomic Solutions for Identifying Aggressive Prostate Cancer,” Dr. Kirk Wojno covers how specific prostate biomarker tests are critical for early detection, diagnosis and treatment of patients. As with any cancer, when it is detected early, it can save lives. As Sen. Elizabeth Dole, a caregiver to her Veteran husband Sen. Bob Dole, affirmed, “Caregivers are with their Veteran at every step of the prostate cancer journey. We must ensure they’re equipped with the information and tools they need to make informed decisions about their care.”